COPANLISIB TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MARGINAL ZONE LYMPHOMA. (12th June 2019) - Panayiotidis, P.; Kellner, A.; Follows, G.A.; Mollica, L.; Nagler, A.; Özcan, M.; Santoro, A.; Hiemeyer, F.; Liu, L.; Garcia‐Vargas, J.; Childs, B.H.; Zinzani, P.L.; et al.